Robust expansion plan; focus remains on improving margins
Motilal Oswal
Summary | Date | Stock | Author | LTP | Target | Price at reco (Change since reco%) |
Upside(%) | Type | Report | Discuss | |
---|---|---|---|---|---|---|---|---|---|---|---|
28 Aug 2023 | Dalmia Bharat |
Motilal Oswal
|
1916.80 | 2400.00 | 2031.85 (-5.66%) | Target met |
Buy
|
||||
28 Aug 2023 | Birla Corporation |
Axis Direct
|
1057.40 | 1250.00 | 1128.20 (-6.28%) | Target met |
Buy
|
||||
27 Aug 2023 | MphasiS |
Motilal Oswal
|
2387.30 | 2250.00 | 2392.10 (-0.20%) | Target met |
Neutral
|
||||
24 Aug 2023 | Dr. Reddy's Labs |
Geojit BNP Paribas
|
1155.90 | 6212.00 | 5907.15 (-80.43%) | Target met |
Hold
|
||||
23 Aug 2023 | Aurobindo Pharma |
Geojit BNP Paribas
|
1164.40 | 915.00 | 838.85 (38.81%) | Target met |
Hold
|
||||
23 Aug 2023 | Oberoi Realty |
Geojit BNP Paribas
|
1534.20 | 936.00 | 1097.20 (39.83%) |
Sell
|
|||||
23 Aug 2023 | Reliance Industries |
ICICI Securities Limited
|
1377.20 | 2650.00 | 2519.40 (-45.34%) | Target met |
Accumulate
|
FY23 Annual Report – broad-based earnings strength; FCF remains negative
ICICI Securities Limited
The FY23 annual report of Reliance Industries (RIL) throws up some interesting data points: i) Capex of INR 1.4trn had grown by a material INR 423bn in FY23, ii) resultant, net debt (including spectrum and other deferred payment liabilities) expanded sharply to INR 1.05trn, despite a material INR 428bn of increase in cash + equivalents for the year.
|
|||
22 Aug 2023 | ITC |
Geojit BNP Paribas
|
423.55 | 478.00 | 454.25 (-6.76%) | Target met |
Hold
|
||||
21 Aug 2023 | Bandhan Bank |
Geojit BNP Paribas
|
156.26 | 269.00 | 230.55 (-32.22%) |
Buy
|
|||||
21 Aug 2023 | Vodafone Idea |
Geojit BNP Paribas
|
6.70 | 6.70 | 7.55 (-11.26%) |
Sell
|
|||||
more
loading
|